Starting a cholesterol-lowering drug before heart artery opening
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if giving a PCSK9 inhibitor (a strong cholesterol-lowering medicine) before a procedure to open blocked heart arteries can help patients who are having a heart attack. It may reduce damage and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You are having a heart attack (STEMI or NSTEMI) and need a procedure to open blocked arteries.
- You have not taken a PCSK9 inhibitor before.
- You do not have a history of bleeding stroke, old heart attack, heart failure, or prior heart artery procedures.
- You are not pregnant or breastfeeding and are not in another clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a powerful cholesterol-lowering drug (PCSK9 inhibitor) very early after a heart attack can help prevent further heart problems. It is for people who have had a recent heart attack and have blockages in more than one heart artery.
This study tests whether starting the cholesterol-lowering drug tafolecimab (a PCSK9 inhibitor) early after a heart procedure (PCI) can help people with acute coronary syndrome. It may help lower LDL cholesterol and reduce future heart risks.
This trial studies whether starting a PCSK9-blocking medicine early after a specific type of heart attack can improve heart outcomes. You may be eligible if you have a STEMI heart attack soon, are planning a procedure to open the blocked artery, and meet safety and pregnancy criteria.
This trial studies whether starting a cholesterol-lowering medicine called a PCSK9 inhibitor early after a heart attack can improve heart health and outcomes. It focuses on people who had a recent heart-artery procedure to fix the blockage in the left anterior descending (LAD) artery.
This study tests whether starting a cholesterol-lowering drug called a PCSK9 inhibitor soon after a heart attack can help prevent future blockages. If you had a heart attack, received a stent, and have other arteries with minor blockages, this trial may be for you.
This trial tests whether giving a PCSK9 inhibitor (a type of cholesterol-lowering medicine) early after a stroke can improve recovery and lower 'bad' cholesterol. It is for people who have had a non-cardioembolic stroke (not from a heart problem) caused by hardening of the arteries.
Hear when a new Acute Myocardial Infarction (AMI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.